Results 61 to 70 of about 29,860 (191)

Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid

open access: yesScientific Reports
The treatment of multidrug-resistant tracheobronchial tuberculosis poses challenges, and research investigating the efficacy of bedaquiline or delamanid as treatment for this condition is limited.
Qing Chen   +14 more
doaj   +1 more source

Targeting bedaquiline mycobacterial efflux pump to potentially enhance therapy in Mycobacterium abscessus

open access: yesInternational Journal of Mycobacteriology, 2020
Background: Mycobacterium abscessus is notorious for being intrinsically resistant to most antibiotics. Antibiotic efflux is one of the mechanisms used by M. abscessus to pump out antibiotics from their cells.
Anandi Martin   +5 more
doaj   +1 more source

Bactericidal activity against M. leprae THAI53 of bedaquiline administered orally and bedaquiline long-acting measured in Swiss mice by the proportional bactericidal method.

open access: yes, 2023
Bactericidal activity against M. leprae THAI53 of bedaquiline administered orally and bedaquiline long-acting measured in Swiss mice by the proportional bactericidal method.
Aurélie Chauffour (485000)   +5 more
core   +1 more source

The Antimycobacterial Activity, Toxicity and Chemical Composition of South African Propolis

open access: yesChemistry &Biodiversity, Volume 23, Issue 8, August 2026.
This study presents one of the largest geographically diverse propolis collections reported globally, comprising 109 samples sourced from eight provinces across South Africa. The novelty of this work lies in the fact that it presents the first investigation of South African propolis against M. tuberculosis.
Nyiko F. Mzimba   +6 more
wiley   +1 more source

Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

open access: yesBMC Infectious Diseases, 2021
Background Drug-resistant tuberculosis (DR-TB) remains a major public health concern worldwide. Bedaquiline, a novel diarylquinoline, was added to the WHO-recommended all-oral regimen for patients with multidrug-resistant tuberculosis.
Ming-Gui Wang   +2 more
doaj   +1 more source

Clinical guideline highlights for the hospitalist: Updates on the treatment of drug‐susceptible and drug‐resistant tuberculosis

open access: yes
Journal of Hospital Medicine, EarlyView.
Allison Stickles   +3 more
wiley   +1 more source

Preserved Spermatogenesis and Hormonal Function in Men Receiving a Pretomanid Regimen (BPaMZ) for Pulmonary Drug‐Resistant Tuberculosis

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 501-509, August 2026.
Pretomanid is a component of the World Health Organization‐recommended treatment regimen for drug‐resistant tuberculosis in patients aged ≥ 14 years. While preclinical rodent studies identified testicular toxicity as a potential clinical liability at elevated doses, no corresponding effects were observed in nonhuman primates nor clinical hormone ...
Pauline Howell   +13 more
wiley   +1 more source

De novo or Salvage? Nucleotide Availability as a Driver of Bacterial Adaptation and Virulence

open access: yesMicrobiologyOpen, Volume 15, Issue 4, August 2026.
Bacterial pathogens survive in different host environments by switching between making nucleotides by de novo synthesis and scavenging them from the host. This flexibility supports growth and virulence making nucleotide metabolism an attractive therapeutic target.
Riya Joshi   +2 more
wiley   +1 more source

Effectiveness and Safety of the Regimens Containing Bedaquiline in Patients with TB and HIV-infection

open access: yesТуберкулез и болезни лёгких
The objective: to analyze effectiveness and safety of bedaquiline administered concurrently with antiretroviral therapy in treatment regimens for patients with such comorbidities as HIV infection and multiple drug resistant and extensively drug resistant
S. B. Borisova, N. Yu. Borodina
doaj   +1 more source

MetF‐Dependent Methionine Biosynthesis Is Required for Mycobacterium tuberculosis Survival and In Vivo Persistence

open access: yesMicrobiologyOpen, Volume 15, Issue 4, August 2026.
MetF is essential for both in vitro and in vivo growth of Mycobacterium tuberculosis, whereas MetE, previously considered essential in vitro, is dispensable in vivo. Given the importance of methionine and folate metabolism as drug targets, MetF represents a promising candidate, highlighting the need for in vivo validation.
Ikue Tosa   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy